Skip to main content

Month: April 2024

[Press Release] iliad SA successfully completes a €500 million bond issue

PRESS RELEASE Paris, April 22, 2024 iliad SA successfully completes a €500 million bond issuefinancial release   Today, iliad SA successfully placed a €500 million bond issue. The bonds will mature in 7 years and pay interest at 5.375% per year. This transaction was announced for a maximum amount of €500 million and generated strong demand from investors (with close to €1.6 billion in demand), which allows the Group to benefit from attractive financial conditions in a context of volatile markets. Such a result in this context once again attests of the investors’ confidence in the quality of the iliad name. This reputation, acquired through a pro active and prudent management of the Group’s liquidity, also demonstrates in light of our recent annual results, that we achieved to convince of our ambition to become Europe’s fifth-largest mobile...

Continue reading

GLUCOTRACK ANNOUNCES CLOSING OF PRIVATE PLACEMENT

Rutherford, NJ, April 22, 2024 (GLOBE NEWSWIRE) — Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that the Company has closed a private placement of securities. The Offering included participation by CEO Paul V. Goode, PhD, as well as other members of the Company’s executive management, Board of Directors, and existing shareholders. In a transaction exempt from registration under Section 4(a)(2) of the Securities Act of 1933, the Company issued 396,825 shares of its common stock at a price of $1.26 per share, for aggregate gross proceeds of $500,000 (the “Offering”). There were no warrants issued and no commissions or brokerage fees paid in connection with the Offering....

Continue reading

Xos, Inc. Announces First Quarter 2024 Earnings Release Date and Conference Call

LOS ANGELES, April 22, 2024 (GLOBE NEWSWIRE) — Xos, Inc. (NASDAQ: XOS), a leading electric truck manufacturer and fleet services provider, announced it will release its first quarter 2024 operating results on Wednesday, May 15, 2024 after the close of the U.S. financial markets. Management will host a conference call to discuss these financial results at 4:30 p.m. Eastern Daylight Time / 1:30 p.m. Pacific Daylight Time that same day. Conference Call and Webcast DetailsDate / Time: Wednesday, May 15, 2024, at 4:30 p.m. EDT / 1:30 p.m. PDTWebcast: https://viavid.webcasts.com/starthere.jsp?ei=1667727&tp_key=3b0fe355e3U.S. Toll-Free Dial In: 1-833-816-1411International Dial In: 1-412-317-0507Conference ID: 10188592   To access the call, please dial in approximately ten minutes before the start of the call. For...

Continue reading

CSX Announces 2024 Customer Environmental Excellence Award Winners

JACKSONVILLE, Fla., April 22, 2024 (GLOBE NEWSWIRE) — CSX (NASDAQ: CSX) CSX Corporation (NASDAQ: CSX) has announced the winners of its 2024 CSX Customer Environmental Excellence Awards. This year’s awards recognizes six customers for their commitment to sustainability by converting a portion of their freight from truck to rail. In the third year of the annual awards program, CSX chose winners who have realized significant carbon reduction by embracing the environmental advantages of rail over trucks with a “highway-to-rail” conversion. “Sustainability is a shared priority between CSX and our customers. Helping them reduce emissions by converting from trucks to rail is an important part of our strategy,” said Kevin Boone, CSX executive vice president and chief commercial officer. “The winners of this year’s awards achieved the highest...

Continue reading

Results of ING’s 2024 Annual General Meeting

Results of ING’s 2024 Annual General Meeting The Annual General Meeting (AGM) of ING Groep N.V. was held today in Amsterdam. The AGM adopted all agenda items, including the annual accounts for 2023, discharge of the members of the Executive Board and the Supervisory Board and the dividend for 2023. Juan Colombás, Herman Hulst and Harold Naus were reappointed as member of the Supervisory Board for a second term of four years. Also, Deloitte Accountants BV was appointed as next external auditor for a term of four years starting on 1 January 2026. Note for editors For further information on ING, please visit www.ing.com. Frequent news updates can be found in the Newsroom or via the @ING_news X feed. Photos of ING operations, buildings and its executives are available for download at Flickr.Press enquiries   Investor enquiriesChristoph...

Continue reading

Greg Tamberlane Joins Peapack Private as Senior Vice President, Head of Commercial Bank Operations New York

PGCGreg Tamberlane, Peapack Private, Senior Vice President, Head of Commercial Bank Operations New YorkBEDMINSTER, NJ, April 22, 2024 (GLOBE NEWSWIRE) — via NewMediaWire — Peapack-Gladstone Financial Corporation (NASDAQ Global Select Market: PGC) and Peapack Private, a division of Peapack-Gladstone Bank, are proud to announce that Greg Tamberlane has been appointed as Senior Vice President, Head of Commercial Bank Operations New York, continuing to lead the expansion of Peapack Private’s New York City location.  Greg will oversee operations for New York, leading a team of financial services professionals to ensure the successful growth of the Company. Greg brings 10 years of financial services experience to Peapack Private, most recently serving as Vice President, Senior Manager of Digital Asset Solutions at Signature...

Continue reading

Intratumoral Injection of Phio’s PH-762 significantly inhibits tumor growth in murine tumor models and may generate memory-specific T cells

-Injection in murine tumors shows the compound is well tolerated -Studies support ongoing clinical trial of PH-762 as a neoadjuvant therapy for treatment of cSCC, melanoma, or Merkel cell carcinoma MARLBOROUGH, Mass., April 22, 2024 (GLOBE NEWSWIRE) — Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ siRNA gene silencing technology is designed to make immune cells more effective in killing tumor cells, today announced it is presenting new data about its lead clinical product candidate, PH-762, an INTASYL compound. Preclinical studies demonstrate:PH-762 is rapidly taken up by cells and robustly silences PD-1 mRNA and protein in lymphocytes within the tumor microenvironment (TME) Intratumoral injection of murine PH-762 (mPH-762) significantly inhibits tumor growth...

Continue reading

Lottery.com, Inc. Nominates Warren Macal to Its Board of Directors

AUSTIN, Texas, April 22, 2024 (GLOBE NEWSWIRE) — Lottery.com Inc. (Nasdaq: LTRY, LTRYW) (“Lottery.com” or the “Company”), a leading technology company in the lottery and gaming sector, is pleased to announce the nomination of Warren Macal to its Board of Directors.   Macal will be seated as a director at the Company’s next Board of Directors meeting following the successful completion of required background checks.   Macal’s nomination follows the December 2023 $18 million investment commitment from Prosperity Investment Management (“PIM”), subject to due diligence. The investment commitment by PIM is aimed at accelerating Lottery.com’s strategic acquisitions and market development initiatives. Warren Macal, currently the Managing Director at PIM and the head of its PIM Motorsport Investment Division, brings more than 15 years...

Continue reading

ScottsMiracle-Gro Partners with Central Ohio Beekeepers Association to Establish Apiary at Corporate Headquarters

MARYSVILLE, Ohio, April 22, 2024 (GLOBE NEWSWIRE) — The Central Ohio Beekeepers Association (COBA) has partnered with ScottsMiracle-Gro brand Ortho®, to establish an apiary, also known as a bee yard, at the Company’s corporate headquarters in Marysville, Ohio. COBA is dedicated to promoting bees and beekeeping in Central Ohio by providing educational opportunities for new beekeepers and continuing education for advanced beekeepers. In 2016, Ortho® announced its decision to remove neonics from its outdoor products after evaluating risks to honeybees and other pollinators. Today, none of Ortho’s outdoor garden care products include neonics. “We recognize that consumers want to protect their homes while also respecting the natural habitat and pollinators,” said Jodi Lee, vice president, brand marketing for gardens and controls at...

Continue reading

Brera Holdings Comments on Top-Level Italian Professional Football Team Acquisition Reports

DUBLIN, Ireland and MILAN, Italy, April 22, 2024 (GLOBE NEWSWIRE) — Brera Holdings PLC (“Brera Holdings,” “Brera” or the “Company”) (Nasdaq: BREA) has been asked to respond to several third-party publications that have reported on Brera’s efforts to acquire a top-level Italian professional football (soccer) team. Brera Holdings CEO, Pierre Galoppi, stated, “In January 2024, we announced that we would begin the process of acquiring a team in the Italian Serie BKT, managed by Lega Nazionale Professionisti Serie B (“Serie B”). We can confirm at this time that we have initiated and are well along on this process with several top caliber and storied teams. In compliance with confidentiality agreements signed with these organizations and with applicable laws, we are not in the position...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.